1. AHRO : Austin Health Research Online

Sabashini K Ramchand

View Statistics Email Alert

Profile

Loading... 2 0 5 0 false
Credit Name
Sabashini K Ramchand
Full Name
Ramchand, Sabashini K
 
Department
 
Loading... 3 0 5 0 false

Publications

Results 1-14 of 14 (Search time: 0.004 seconds).

Publication YearTitleAuthor(s)
128-Jan-2021Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density after Combined Denosumab and Teriparatide Administration: DATA-HD Study Extension.Ramchand, Sabashini K ; David, Natalie L; Lee, Hang; Eastell, Richard; Tsai, Joy N; Leder, Benjamin Z
213-Aug-2020Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: the DATA-HD HR-pQCT Study.Ramchand, Sabashini K ; David, Natalie L; Lee, Hang; Bruce, Michael; Bouxsein, Mary L; Leder, Benjamin Z; Tsai, Joy N
331-Mar-2020Reduced Bone Modeling and Unbalanced Bone Remodeling: Targets for Antiresorptive and Anabolic Therapy.Ramchand, Sabashini K ; Seeman, Ego 
4Mar-2020Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: the DATA-HD RCT.Ramchand, Sabashini K ; David, Natalie L; Leder, Benjamin Z; Tsai, Joy N
5Sep-2019Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: position statement summary.Grossmann, Mathis ; Ramchand, Sabashini K ; Milat, Frances; Vincent, Amanda; Lim, Elgene; Kotowicz, Mark A; Hicks, Jill; Teede, Helena J
61-Jul-2019Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer.Cheung, Yee-Ming; Ramchand, Sabashini K ; Yeo, Belinda ; Grossmann, Mathis 
721-Mar-2019Bone health in women with breast cancer.Ramchand, Sabashini K ; Cheung, Y M; Grossmann, Mathis 
82019The effects of adjuvant endocrine therapy on bone health in women with breast cancer.Ramchand, Sabashini K ; Cheung, Yee-Ming; Yeo, Belinda ; Grossmann, Mathis 
96-Sep-2018Advances and Unmet Needs in the Therapeutics of Bone Fragility.Ramchand, Sabashini K ; Seeman, Ego 
109-May-2018Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian Menopause Society and the Clinical Oncology Society of Australia.Grossmann, Mathis ; Ramchand, Sabashini K ; Milat, Frances; Vincent, Amanda; Lim, Elgene; Kotowicz, Mark A; Hicks, Jill; Teede, Helena
112018The Influence of Cortical Porosity on the Strength of Bone During Growth and Advancing Age.Ramchand, Sabashini K ; Seeman, Ego 
12Oct-2017Premenopausal women with early breast cancer treated with estradiol suppression have severely deteriorated bone microstructure.Ramchand, Sabashini K ; Seeman, Ego ; Wang, Xiao-Fang ; Ghasem-Zadeh, Ali ; Francis, Prudence A; Ponnusamy, Evangeline J; Bardin, Michele S; Bui, Minh; Zebaze, Roger; Zajac, Jeffrey D ; Grossmann, Mathis 
13Sep-2017Higher maternal serum prolactin levels are associated with reduced glucose tolerance during pregnancyEkinci, Elif I ; Torkamani, Niloufar ; Ramchand, Sabashini K ; Churilov, Leonid ; Sikaris, Ken A; Lu, Zhong X; Houlihan, Christine A 
14Nov-2016Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: How should the skeletal and vascular side effects be assessed and managed?Ramchand, Sabashini K ; Lim, Elgene; Grossmann, Mathis